Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment by Ramadori, G. et al.
Histol Histopathol (2001) 16: 1275-1 285 
http://www.ehu.es/histol-histopathol 
Revie W 
Hepatitis C virus-associated mixed 
cryoglobulinemia. Clinical manifestations, 
histopathological changes, mechanisms of 
cryoprecipitation and options of treatment 
P. Schottl, H. Hartmann2 and G. Ramadori3 
Department of Medicine, 'Division of Cardiology, 3Division of Gastroenterology and Endocrinology, 
Georg-August-University, Goettingen and 2St. Martini Hospital, Duderstadt, Germany 
Summary. Chronic hepatitis C virus (HCV) infection is 
frequently associated with a variety of autoimmune 
phenomenons. Mixed cryoglobulinemia (MC) appears in 
up  to  50% o f  c h r o n i c  HCV-infected pat ients .  
Cryoglobulins consist of immunoglobulin complexes 
p rec ip i t a t ing  in vi tro  w h e n  coo led  be low body  
temperature. In most cases IgM with rheumatoid factor 
activity is found in cryoprecipitates which could lead to 
vascul i t i s  induced by the depos i t ion  of  immnuo-  
complexes in small vessels. This vasculitis is thought to 
cause clinical symptoms called Meltzer's triad. This 
triad is represented by purpura, arthralgia and weakness. 
One third of patients suffering from HCV-associated 
mixed c ryog lobu l inemia  are  d e v e l o p i n g  typical  
symptoms during their course of disease. 
The striking association between HCV infection and 
M C  has conduced to the hypothesis that HCV is of 
major importance in the production of MC with followed 
vasculitis. 
Both hepatrophism and lymphotrophism have been 
reported for the hepatitis C virus. Infection of B-cells by 
HCV could probably lead to a bcl-2 translocation and 
immunoglobulin gene rearrangement which results in 
c lona l  lymphopro l i f e ra t ion  and in s y n t h e s i s  of  
monoclonal IgM with rheumatoid factor activity. These 
IgM form immunocomplexes with IgG in the cold,  
which are finally responsible for the described vasculitis. 
Histopathological changes of the liver are dominated 
by chronic HCV infection. The majority of times mild 
activity of hepatitis or mild fibrosis could be found. 
Nevertheless, cirrhosis is more often found in HCV- 
infected patients suffer ing f rom M C  compared to 
patients without MC. 
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Conventional treatment of MC is aimed to reduce 
circulating immune complexes by immunosupression 
and plasmapheresis. With the emerging concept of a 
viral pathogenesis the therapeutic approach has changed 
during the last decade. Interferon treatment of MC, 
particularly of HCV-associated M C  is well established 
nowadays. 
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The syndrome of cryoglobulinemia, a historical 
review 
A s  ear ly  a s  1929 the  phenomenon  of  
c ryoprec ip i t a t ion  d u r i n g  fo rmat ion  of  immune  
complexes was described by Heidelberger and Kendall 
(1929). Cold-induced precipitation of serum proteins 
was  observed in a patient suffer ing from multiple 
myeloma in 1933 for the first time (Wintrobe and Buell, 
1933). In 1947 the  t e rm c ryog lobu l inemia  w a s  
es t ab l i shed  fo r  the  s y n d r o m e  of  p rec ip i t a t ing  
immunglobulins in the cold (Lerner and Watson, 1947). 
Typ ica l  c l in ica l  s y m p t o m s  assoc ia ted  with 
cryoglobulinemia, particularly the triad of arthralgia, 
purpura and weakness were described by Meltzer and 
Franklin (1966). T h e  clinical  manifestation of the 
s y n d r o m e  i s  thought  to  be caused by depos i t s  of  
circulating immune complexes in small  vessels via 
complement activation (Meltzer and Franklin, 1966; 
Brouet et al., 1974; Invernizzi et al., 1979; Gross, 1994; 
Gumber and Chopra, 1995). In 1974 Rrouet et al. (1974) 
desc r ibed  the compos i t ion  o f  c ryog lobu l ins  and 
proposed a classification of cryoglobulinemia into type I, 
11 and Il l  based on the type of immunoglobulin that 
constitutes the cryoprecipitate. 










